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pean Biochemical Societies (FEBS), which was founded 50 years
ago in 1964 [1]. As the 50th anniversary of FEBS draws to a close,
there is another anniversary to mark – the launch three
years ago of the newest member in the FEBS journal family:
FEBS Open Bio.
Journal publishing has been a core activity of FEBS from the very
beginning. FEBS was only three years old when it launched the
European Journal of Biochemistry (the original title of The FEBS Jour-
nal) in 1967, closely followed by FEBS Letters in 1968. These two
journals rapidly grew into inﬂuential and respected forums for
the dissemination of primary papers and reviews in biochemistry
and molecular biology. The popularity of The FEBS Journal and FEBS
Letters within the scientiﬁc community and their consequent
ﬁnancial success have enabled FEBS to run numerous scientiﬁc
meetings and training courses and to broaden its activities,
promoting the molecular life sciences in Europe and beyond.
More recently (in 2007), FEBS launched a new journal, Molecular
Oncology, to serve the cancer community and this has also been a
resounding success.
Responding to the growing interest in, and demand for, open
access publishing, FEBS felt that the time was right to extend its
portfolio once again in 2011 when it launched FEBS Open Bio, in
partnership with Elsevier. The journal is published online only,
with free access of all content to all readers. Authors of accepted
articles are charged a fee towards the costs of publication; a policy
is in place to assist those who do not have funding for such charges.
With the emergence of numerous open-access journals of vari-
able quality in recent years [2], FEBS was keen that FEBS Open Bio
should adhere to the same rigorous standards of peer review as
its sister journals. The founding editorial board was formed from
members of the editorial boards of The FEBS Journal, FEBS Letters
andMolecular Oncology, with the appointment of additional editors
as the journal has grown.
While its sister journals select papers for their impact, the focus
of the peer review process for FEBS Open Bio is on the technical
soundness of manuscripts, leaving the assessment of their impact
and biological signiﬁcance to the scientiﬁc community. This puts
FEBS Open Bio in the category of ‘megajournals’ [3] such as PLOS
One and Scientiﬁc Reports.
The scope of FEBS Open Bio is broad, covering all of the molecu-
lar and cellular life sciences. Some of the most highly downloaded
and cited papers published so far have included bioinformatics
studies [4,5], a report of a bacteriocin against both Gram-negative
and -positive bacteria [6], an analysis of the ATAF1 transcription
factor, which plays important roles in plant development and
adaptation to environmental stress [7], and a kinetic analysis of
the clinical anti-cancer candidate PG545 [8]. Submission of noveland innovative work is of course greatly encouraged, but papers
describing solid science in developing ﬁelds or extending knowl-
edge from one organism to another are also considered. FEBS Open
Bio is also keen to receive papers reporting negative results, which
are a valuable service to the community by avoiding the unneces-
sary duplication of effort and wasting of resources.
In addition to direct submissions, articles originally submitted
to other FEBS journals, which the Editors of those journals judge
to be scientiﬁcally sound but of insufﬁcient general interest, can
be transferred to FEBS Open Bio. The reviews solicited by the Editors
of the original journals are transferred along with the manuscript,
thus conserving the peer review process and offering authors a
fast-track alternative for publication of their paper.
FEBS Open Bio prides itself on both rapid peer review and pub-
lication, and publishes these and other metrics on its home page
(see http://journalinsights.elsevier.com/journals/2211-5463). The
average time to ﬁrst decision was 3.2 weeks in 2013, and articles
are published online within a week of acceptance.
FEBS Open Bio assists authors in sharing their data. The HTML
versions of articles include hyperlinks to data deposited in publicly
available databases and structural data can be viewed within arti-
cles using the Protein Viewer, as in this report on the structure and
function of a fasciclin I (FAS1) domain protein [9]. Authors are
encouraged to include usable data sets as supplementary materi-
als, such as for this highly downloaded paper describing mRNA
and miRNA transcriptomes for nasopharyngeal carcinoma cell
lines [10].
Authors of articles in FEBS Open Bio retain copyright and are
able to post additional copies of the ﬁnal version of their manu-
script on any website of their choice, thus ensuring the widest pos-
sible audience for their work. FEBS Open Bio is already indexed in
Chemical Abstracts, EMBASE, Exerpta Medica, Scopus, PubMed,
PubMed Central and Europe PubMed Central. We are pleased to
announce that Thomson Reuters has now accepted the journal
for indexing in Science Citation Index Expanded (accessed through
Web of Science), Biological Abstracts and BIOSIS Previews. Inclu-
sion in Journal Citation Reports/Science Edition means that FEBS
Open Bio will receive an Impact Factor for 2014 in the summer of
2015.
While welcoming the forthcoming award of an Impact Factor as
a mark of the quality of the journal as a whole, FEBS Open Bio is a
signatory of the San Francisco Declaration on Research Assessment
(DORA), a set of recommendations that calls for the ‘need to assess
research on its merits rather than on the basis of the Impact Factor
of the journal in which the research is published’ [11]. Citation data
is available on individual articles published in FEBS Open Bio and
authors have access to a ‘dashboard’ providing other metrics of
the impact of their article (see http://www.elsevier.com/connect/
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As the 2014 volume closes, FEBS Open Bio has already published
over 250 articles. We look forward to an even busier 2015 and
hope that you will consider FEBS Open Bio when looking to publish
your next paper.
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